Management of recurrent gastrointestinal cancer with ripretinib and surgery

Deutschland Nachrichten Nachrichten

Management of recurrent gastrointestinal cancer with ripretinib and surgery
Deutschland Neuesten Nachrichten,Deutschland Schlagzeilen
  • 📰 medical_xpress
  • ⏱ Reading Time:
  • 45 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 21%
  • Publisher: 51%

Ripretinib is a tyrosine kinase inhibitor that was approved by the United States FDA in 2020 for treatment of advanced gastrointestinal stromal tumor (GIST) in patients who received prior treatment with three or more tyrosine kinase inhibitors.

retrieved 6 November 2023 from https://medicalxpress.com/news/2023-11-recurrent-gastrointestinal-cancer-ripretinib-surgery.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.Use this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use ourThank you for taking time to provide your feedback to the editors.

Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.Get weekly and/or daily updates delivered to your inbox.

Wir haben diese Nachrichten zusammengefasst, damit Sie sie schnell lesen können. Wenn Sie sich für die Nachrichten interessieren, können Sie den vollständigen Text hier lesen. Weiterlesen:

medical_xpress /  🏆 101. in UK

Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen

Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.

Using ripretinib and surgery to manage recurrent gastrointestinal stromal tumorUsing ripretinib and surgery to manage recurrent gastrointestinal stromal tumorA new case report was published in Oncoscience (Volume 10) on September 20, 2023, entitled, 'Multi-disciplinary management of recurrent gastrointestinal stromal tumor harboring KIT exon 11 mutation with the switch-control kinase inhibitor ripretinib and surgery.
Weiterlesen »

Logan Paul calls out first opponent for crazy WWE match after winning United States ChampionshipLogan Paul calls out first opponent for crazy WWE match after winning United States ChampionshipLogan Paul has called out his first opponent after winning the United States Championship from Rey Mysterio at WWE Crown Jewel.
Weiterlesen »

Haas right of review hearing into US GP result confirmed as Red Bull, Williams, Aston Martin also calledHaas right of review hearing into US GP result confirmed as Red Bull, Williams, Aston Martin also calledHighlights from the United States Grand Prix at the Circuit of the Americas
Weiterlesen »

Haas seeks FIA right of review over alleged illegal actions in AustinThe United States Grand Prix result may not be set in stone...
Weiterlesen »

Manchester City join Man Utd in race to sign Belfast teen prospectManchester City join Man Utd in race to sign Belfast teen prospectCoran Madden (14) has already been on trial with Newcastle United and Manchester United
Weiterlesen »

Manchester City join Man Utd in race to sign Belfast teen prospectManchester City join Man Utd in race to sign Belfast teen prospectCoran Madden (14) has already been on trial with Newcastle United and Manchester United
Weiterlesen »



Render Time: 2025-02-27 08:02:23